20.05.2021 • News

Arkema to Acquire Edge Adhesives Texas

French specialty chemicals producer Arkema said it plans to acquire Edge Adhesives Texas, as “a complementary asset” that will boost subsidiary Bostik’s offerings in high performance adhesives in the US. Financial terms were not disclosed.

Arkema said the deal, due to close in the current quarter, is in line with its growth strategy of bolt-on acquisitions to develop greater breadth in adhesives and deliver new products to meet expanding demand. It will expand Bostik’s profile and expand its presence in North America, the parent company added.

Edge Adhesives, which operates a plant in Fort Worth, Texas, is regarded as a leading developer and manufacturer of adhesive solutions used in residential buildings. With around 50 employees and annual sales of around $12 million, the company specializes in custom formulations in fast-growing easy-install window, door and roofing applications.

In addition to delivering strong technological, industrial and commercial synergies, Arkema said the acquisition will enable Bostik to offer its customers an extended range of value-added and sustainable solutions in hot-melt pressure sensitive adhesives. Based in Colombes, France, the company with annual sales of €2.1 billion develops, manufactures and distributes specialty adhesives and sealants for construction, industrial and consumer markets.

Author: Dede Williams, Freelance Journalist

Arkema plans to acquire Edge Adhesives Texas to boost subsidiary Bostik’s...
Arkema plans to acquire Edge Adhesives Texas to boost subsidiary Bostik’s offerings in high performance adhesives in the US. Financial terms of the deal, due to close during the current quarter, were not disclosed. The Texas firm has annual sales of $12 million and 50 employees. (c) Arkema

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.